These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 19643258)

  • 1. Long-term results of endolymphatic mastoid shunt surgery in patients with intractable Ménière's disease.
    Yu MS; Lee KS; Chung JW
    Otolaryngol Head Neck Surg; 2009 Aug; 141(2):237-42. PubMed ID: 19643258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of long-term hearing results after vestibular neurectomy, endolymphatic mastoid shunt, and medical therapy.
    Quaranta A; Onofri M; Sallustio V; Iurato S
    Am J Otol; 1997 Jul; 18(4):444-8. PubMed ID: 9233483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endolymphatic mastoid shunt versus endolymphatic sac decompression for Ménière's disease.
    Brinson GM; Chen DA; Arriaga MA
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3):415-21. PubMed ID: 17321870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple semicircular canal occlusion for the treatment of Ménière's disease.
    Yin S; Chen Z; Yu D; Wu Y; Shi H; Zhou H; Wang J
    Acta Otolaryngol; 2008 Jul; 128(7):739-43. PubMed ID: 18568514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of hearing preservation after endolymphatic mastoid sac surgery for Meniere's disease.
    Sun GH; Leung R; Samy RN; McAfee JS; Hearst MJ; Savage CR; Choo DI; Pensak ML
    Laryngoscope; 2010 Mar; 120(3):591-7. PubMed ID: 20131368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endolymphatic mastoid shunt surgery in the managed care era.
    Pensak ML; Friedman RA
    Am J Otol; 1998 May; 19(3):337-40. PubMed ID: 9596185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endolymphatic sac surgery for Ménière's disease: long-term results after primary and revision surgery.
    Wetmore SJ
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1144-8. PubMed ID: 19015441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three new surgeries for treatment of intractable Meniere's disease.
    Huang TS
    Am J Otol; 1999 Mar; 20(2):233-7. PubMed ID: 10100528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
    Li CS; Lai JT
    Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endolymphatic mastoid shunt surgery in unilateral Menière's disease.
    Moffat DA
    Ear Nose Throat J; 1997 Sep; 76(9):642-3, 647-8, 650-1. PubMed ID: 9309907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 10-year review of endolymphatic sac surgery for intractable meniere disease.
    Hu A; Parnes LS
    J Otolaryngol Head Neck Surg; 2010 Aug; 39(4):415-21. PubMed ID: 20643008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endolymphatic mastoid shunt for Menière's disease: do results change over time?
    Goldenberg RA; Justus MA
    Laryngoscope; 1990 Feb; 100(2 Pt 1):141-5. PubMed ID: 2299954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endolymphatic sac decompression as a treatment for Meniere's disease.
    Durland WF; Pyle GM; Connor NP
    Laryngoscope; 2005 Aug; 115(8):1454-7. PubMed ID: 16094123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of Ménière's disease: endolymphatic mastoid shunt versus natural history.
    Quaranta A; Marini F; Sallustio V
    Audiol Neurootol; 1998; 3(1):54-60. PubMed ID: 9502541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term audition results in patients with chronic endolymphatic hydrops after selective vestibular neurotomy and endolymphatic sac surgery].
    Quaranta N; De Thomasis G; Gandolfi A; Piazza F; Zini C; Quaranta A
    Acta Otorhinolaryngol Ital; 2001 Jun; 21(3):131-7. PubMed ID: 11677838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summating potential and action potential ratio in Meniere's disease before and after treatment.
    Orchik DJ; Shea JJ; Ge NN
    Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.